{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:23:39Z","timestamp":1782221019230,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dent disease is an X-linked disorder characterized by low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis and chronic kidney disease (CKD). It is caused by mutations in the chloride voltage-gated channel 5 (<jats:italic>CLCN5<\/jats:italic>) gene (Dent disease-1), or in the <jats:italic>OCRL<\/jats:italic> gene (Dent disease-2). It is associated with chronic metabolic acidosis; however metabolic alkalosis has rarely been reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a family with Dent-2 disease and a Bartter-like phenotype. The main clinical problems observed in the proband included a) primary phosphaturia leading to osteomalacia and stunted growth; b) elevated serum calcitriol levels, leading to hypercalcemia, hypercalciuria, nephrolithiasis and nephrocalcinosis; c) severe salt wasting causing hypotension, hyperaldosteronism, hypokalemia and metabolic alkalosis; d) partial nephrogenic diabetes insipidus attributed to hypercalcemia, hypokalemia and nephrocalcinosis; e) albuminuria, LMWP.<\/jats:p>\n                <jats:p>Phosphorous repletion resulted in abrupt cessation of hypercalciuria and significant improvement of hypophosphatemia, physical stamina and bone histology. Years later, he presented progressive CKD with nephrotic range proteinuria attributed to focal segmental glomerulosclerosis (FSGS). Targeted genetic analysis for several phosphaturic diseases was unsuccessful. Whole Exome Sequencing (WES) revealed a c.1893C\u2009&gt;\u2009A variant (Asp631Glu) in the <jats:italic>OCRL<\/jats:italic> gene which was co-segregated with the disease in male family members.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We present the clinical characteristics of the Asp631Glu mutation in the <jats:italic>OCRL<\/jats:italic> gene, presenting as Dent-2 disease with Bartter-like features. Phosphorous repletion resulted in significant improvement of all clinical features except for progressive CKD. Angiotensin blockade improved proteinuria and stabilized kidney function for several years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02812-9","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T09:03:15Z","timestamp":1652346195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene"],"prefix":"10.1186","volume":"23","author":[{"given":"Eleni","family":"Drosataki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevasti","family":"Maragkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleio","family":"Dermitzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Stavrakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Lygerou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Latsoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pleros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Zaganas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-9421","authenticated-orcid":false,"given":"Kostas","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"2","key":"2812_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.kint.2016.04.022","volume":"90","author":"A Blanchard","year":"2016","unstructured":"Blanchard A, Curis E, Guyon-Roger T, et al. Observations of a large Dent disease cohort. Kidney Int. 2016;90(2):430\u20139. https:\/\/doi.org\/10.1016\/j.kint.2016.04.022.","journal-title":"Kidney Int"},{"issue":"2","key":"2812_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1086\/427887","volume":"76","author":"RR Hoopes","year":"2005","unstructured":"Hoopes RR, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am J Hum Genet. 2005;76(2):260\u20137. https:\/\/doi.org\/10.1086\/427887.","journal-title":"Am J Hum Genet"},{"key":"2812_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1172-5-28","volume":"5","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Thakker RV. Dent's disease. Orphanet J Rare Dis. 2010;5:28. https:\/\/doi.org\/10.1186\/1750-1172-5-28.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2812_CR4","doi-asserted-by":"publisher","first-page":"p27","DOI":"10.1159\/000213506","volume":"112","author":"AE Shrimpton","year":"2009","unstructured":"Shrimpton AE, Hoopes RR, Knohl SJ, et al. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol. 2009;112(2):p27\u201336. https:\/\/doi.org\/10.1159\/000213506.","journal-title":"Nephron Physiol"},{"issue":"11","key":"2812_CR5","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978\u201380. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897.","journal-title":"Bioinformatics"},{"key":"2812_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/adc.39.205.240","volume":"39","author":"CE Dent","year":"1964","unstructured":"Dent CE, Friedman M. Hypercalcuric rickets associated with renal tubular damage. Arch Dis Child. 1964;39:240\u20139. https:\/\/doi.org\/10.1136\/adc.39.205.240.","journal-title":"Arch Dis Child"},{"issue":"12","key":"2812_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/hmg\/2.12.2129","volume":"2","author":"MA Pook","year":"1993","unstructured":"Pook MA, Wrong O, Wooding C, Norden AG, Feest TG, Thakker RV. Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum Mol Genet. 1993;2(12):2129\u201334. https:\/\/doi.org\/10.1093\/hmg\/2.12.2129.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2812_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1006\/geno.1995.9960","volume":"29","author":"SE Fisher","year":"1995","unstructured":"Fisher SE, van Bakel I, Lloyd SE, Pearce SH, Thakker RV, Craig IW. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics. 1995;29(3):598\u2013606. https:\/\/doi.org\/10.1006\/geno.1995.9960.","journal-title":"Genomics."},{"issue":"1","key":"2812_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpeds.2009.01.049","volume":"155","author":"A B\u00f6kenkamp","year":"2009","unstructured":"B\u00f6kenkamp A, B\u00f6ckenhauer D, Cheong HI, et al. Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr. 2009;155(1):94\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2009.01.049.","journal-title":"J Pediatr"},{"issue":"5","key":"2812_CR10","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/j.1523-1755.2004.00571.x","volume":"65","author":"RR Hoopes Jr","year":"2004","unstructured":"Hoopes RR Jr, Raja KM, Koich A, et al. Evidence for genetic heterogeneity in Dent's disease. Kidney Int. 2004;65(5):1615\u201320. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00571.x.","journal-title":"Kidney Int"},{"issue":"10","key":"2812_CR11","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1093\/ndt\/gfl346","volume":"21","author":"M Ludwig","year":"2006","unstructured":"Ludwig M, Utsch B, Monnens LA. Recent advances in understanding the clinical and genetic heterogeneity of Dent's disease. Nephrol Dial Transplant. 2006;21(10):2708\u201317. https:\/\/doi.org\/10.1093\/ndt\/gfl346.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"2812_CR12","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-009-1228-4","volume":"24","author":"E Tosetto","year":"2009","unstructured":"Tosetto E, Addis M, Caridi G, et al. Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations. Pediatr Nephrol. 2009;24(10):1967\u201373. https:\/\/doi.org\/10.1007\/s00467-009-1228-4.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2812_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00439-020-02219-2","volume":"140","author":"L Gianesello","year":"2021","unstructured":"Gianesello L, Del Prete D, Anglani F, Cal\u00f2 LA. Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon. Hum Genet. 2021;140(3):401\u201321. https:\/\/doi.org\/10.1007\/s00439-020-02219-2.","journal-title":"Hum Genet"},{"issue":"2","key":"2812_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ajmg.a.38572","volume":"176","author":"E Abdalla","year":"2018","unstructured":"Abdalla E, El-Beheiry A, Dieterich K, Thevenon J, Faur\u00e9 J, Rendu J. Lowe syndrome: a particularly severe phenotype without clinical kidney involvement. Am J Med Genet A. 2018;176(2):460\u20134. https:\/\/doi.org\/10.1002\/ajmg.a.38572.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2812_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.21391","volume":"32","author":"H Hichri","year":"2011","unstructured":"Hichri H, Rendu J, Monnier N, et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat. 2011;32(4):379\u201388. https:\/\/doi.org\/10.1002\/humu.21391.","journal-title":"Hum Mutat"},{"issue":"6","key":"2812_CR16","doi-asserted-by":"publisher","first-page":"942 e1","DOI":"10.1053\/j.ajkd.2006.08.018","volume":"48","author":"B Utsch","year":"2006","unstructured":"Utsch B, Bokenkamp A, Benz MR, et al. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis. 2006;48(6):942 e1\u201314. https:\/\/doi.org\/10.1053\/j.ajkd.2006.08.018.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2812_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2215\/CJN.00900207","volume":"2","author":"L Copelovitch","year":"2007","unstructured":"Copelovitch L, Nash MA, Kaplan BS. Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol. 2007;2(5):914\u20138. https:\/\/doi.org\/10.2215\/CJN.00900207.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2812_CR18","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.2215\/CJN.03710416","volume":"11","author":"X Wang","year":"2016","unstructured":"Wang X, Anglani F, Beara-Lasic L, et al. Glomerular pathology in Dent disease and its association with kidney function. Clin J Am Soc Nephrol. 2016;11(12):2168\u201376. https:\/\/doi.org\/10.2215\/CJN.03710416.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2812_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/ndt\/gfw350","volume":"33","author":"M Zaniew","year":"2018","unstructured":"Zaniew M, B\u00f6kenkamp A, Kolbuc M, et al. Long-term renal outcome in children with OCRL mutations: retrospective analysis of a large international cohort. Nephrol Dial Transplant. 2018;33(1):85\u201394. https:\/\/doi.org\/10.1093\/ndt\/gfw350.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2812_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00467-016-3343-3","volume":"31","author":"A B\u00f6kenkamp","year":"2016","unstructured":"B\u00f6kenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update. Pediatr Nephrol. 2016;31(12):2201\u201312. https:\/\/doi.org\/10.1007\/s00467-016-3343-3.","journal-title":"Pediatr Nephrol"},{"issue":"24","key":"2812_CR21","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1038\/emboj.2011.354","volume":"30","author":"M Vicinanza","year":"2011","unstructured":"Vicinanza M, Di Campli A, Polishchuk E, et al. OCRL controls trafficking through early endosomes via PtdIns4,5P2-dependent regulation of endosomal actin. EMBO J. 2011;30(24):4970\u201385. https:\/\/doi.org\/10.1038\/emboj.2011.354.","journal-title":"EMBO J"},{"issue":"3","key":"2812_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1681\/ASN.2010050565","volume":"22","author":"SP Bothwell","year":"2011","unstructured":"Bothwell SP, Chan E, Bernardini IM, Kuo YM, Gahl WA, Nussbaum RL. Mouse model for Lowe syndrome\/Dent disease 2 renal tubulopathy. J Am Soc Nephrol. 2011;22(3):443\u20138. https:\/\/doi.org\/10.1681\/ASN.2010050565.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2812_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.kint.2020.05.040","volume":"98","author":"M Berquez","year":"2020","unstructured":"Berquez M, Gadsby JR, Festa BP, et al. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease. Kidney Int. 2020;98(4):883\u201396. https:\/\/doi.org\/10.1016\/j.kint.2020.05.040.","journal-title":"Kidney Int"},{"issue":"7","key":"2812_CR24","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/ndt\/16.7.1512","volume":"16","author":"HK Burgess","year":"2001","unstructured":"Burgess HK, Jayawardene SA, Velasco N. Dent's disease: can we slow its progression? Nephrol Dial Transplant. 2001;16(7):1512\u20133. https:\/\/doi.org\/10.1093\/ndt\/16.7.1512.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2812_CR25","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1097\/01.asn.0000036869.82685.f6","volume":"13","author":"KA Raja","year":"2002","unstructured":"Raja KA, Schurman S, D'Mello RG, et al. Responsiveness of hypercalciuria to thiazide in Dent's disease. J Am Soc Nephrol. 2002;13(12):2938\u201344. https:\/\/doi.org\/10.1097\/01.asn.0000036869.82685.f6.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2812_CR26","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/j.ajkd.2008.08.021","volume":"52","author":"A Blanchard","year":"2008","unstructured":"Blanchard A, Vargas-Poussou R, Peyrard S, et al. Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial. Am J Kidney Dis. 2008;52(6):1084\u201395. https:\/\/doi.org\/10.1053\/j.ajkd.2008.08.021.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2812_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1523-1755.2005.00442.x","volume":"68","author":"V Cebotaru","year":"2005","unstructured":"Cebotaru V, Kaul S, Devuyst O, et al. High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int. 2005;68(2):642\u201352. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00442.x.","journal-title":"Kidney Int"},{"issue":"3","key":"2812_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/jpem.2008.21.3.279","volume":"21","author":"S Sheffer-Babila","year":"2008","unstructured":"Sheffer-Babila S, Chandra M, Speiser PW. Growth hormone improves growth rate and preserves renal function in Dent disease. J Pediatr Endocrinol Metab. 2008;21(3):279\u201386. https:\/\/doi.org\/10.1515\/jpem.2008.21.3.279.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2812_CR29","first-page":"473","volume":"87","author":"OM Wrong","year":"1994","unstructured":"Wrong OM, Norden AG, Feest TG. Dent\u2019s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM. 1994;87(8):473\u201393.","journal-title":"QJM."},{"issue":"1","key":"2812_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/PGE-2012-005","volume":"1","author":"D B\u00f6ckenhauer","year":"2012","unstructured":"B\u00f6ckenhauer D, B\u00f6kenkamp A, Nuutinen M, et al. Novel OCRL mutations in patients with Dent-2 disease. J Pediatr Genet. 2012;1(1):15\u201323. https:\/\/doi.org\/10.3233\/PGE-2012-005.","journal-title":"J Pediatr Genet"},{"issue":"7","key":"2812_CR31","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/ndt\/gfh799","volume":"20","author":"N Besbas","year":"2005","unstructured":"Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M. CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease. Nephrol Dial Transplant. 2005;20(7):1476\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfh799.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"2812_CR32","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00467-010-1615-x","volume":"25","author":"R Bogdanovi\u0107","year":"2010","unstructured":"Bogdanovi\u0107 R, Draaken M, Toromanovi\u0107 A, Dordevi\u0107 M, Staji\u0107 N, Ludwig M. A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr Nephrol. 2010;25(11):2363\u20138. https:\/\/doi.org\/10.1007\/s00467-010-1615-x.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2812_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00431-011-1578-3","volume":"171","author":"T Okamoto","year":"2012","unstructured":"Okamoto T, Tajima T, Hirayama T, Sasaki S. A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5. Eur J Pediatr. 2012;171(2):401\u20134. https:\/\/doi.org\/10.1007\/s00431-011-1578-3.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"2812_CR34","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/dds105","volume":"21","author":"FM Hannan","year":"2012","unstructured":"Hannan FM, Nesbit MA, Zhang C, et al. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum Mol Genet. 2012;21(12):2768\u201378. https:\/\/doi.org\/10.1093\/hmg\/dds105.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2812_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.berh.2007.11.006","volume":"22","author":"OI Egbuna","year":"2008","unstructured":"Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol. 2008;22(1):129\u201348. https:\/\/doi.org\/10.1016\/j.berh.2007.11.006.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"15","key":"2812_CR36","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","volume":"335","author":"SH Pearce","year":"1996","unstructured":"Pearce SH, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med. 1996;335(15):1115\u201322. https:\/\/doi.org\/10.1056\/NEJM199610103351505.","journal-title":"N Engl J Med"},{"issue":"10","key":"2812_CR37","doi-asserted-by":"publisher","first-page":"C1479","DOI":"10.1152\/ajpcell.00277.2011","volume":"302","author":"G Wu","year":"2012","unstructured":"Wu G, Zhang W, Na T, Jing H, Wu H, Peng JB. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease. Am J Physiol Cell Physiol. 2012;302(10):C1479\u201391. https:\/\/doi.org\/10.1152\/ajpcell.00277.2011.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2812_CR38","first-page":"75","volume":"38","author":"LR Charnas","year":"1991","unstructured":"Charnas LR, Gahl WA. The oculocerebrorenal syndrome of Lowe. Adv Pediatr Infect Dis. 1991;38:75\u2013107.","journal-title":"Adv Pediatr Infect Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02812-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T09:07:29Z","timestamp":1652346449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2812"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02812-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the ethics committee of the University Hospital of Heraklion, with a protocol number 2529\/19-2-2015.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the family members for publication of their own and children\u2019s genetic and clinical data. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}